These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4461779)

  • 1. Dissolution rate and bioavailability of griseofulvin from a ground mixture with microcrystalline cellulose.
    Yamamoto K; Nakano M; Arita T; Nakai Y
    J Pharmacokinet Biopharm; 1974 Dec; 2(6):487-93. PubMed ID: 4461779
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of griseofulvin from a novel capsule formulation.
    Fell JT; Calvert RT; Riley-Bentham P
    J Pharm Pharmacol; 1978 Aug; 30(8):479-82. PubMed ID: 28393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tamaki N; Kamimura H; Katougi Y; Omi Y
    J Pharm Sci; 1982 Oct; 71(10):1169-72. PubMed ID: 7143218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution behavior and bioavailability of phenytoin from a ground mixture with microcrystalline cellulose.
    Yamamoto K; Nakano M; Arita T; Takayama Y; Nakai Y
    J Pharm Sci; 1976 Oct; 65(10):1484-8. PubMed ID: 978407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability of anhydrous griseofulvin and its chloroform solvate in man.
    Bates TR; Fung HL; Lee H; Tembo AV
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):233-43. PubMed ID: 1153870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of griseofulvin from tablets in humans and the correlation with its dissolution rate.
    Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A
    J Pharm Sci; 1982 Oct; 71(10):1165-9. PubMed ID: 7143217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid crystal suspensions containing griseofulvin--preparation and bioavailability testing.
    Reitz E; Vervaet C; Neubert RH; Thommes M
    Eur J Pharm Biopharm; 2013 Feb; 83(2):193-202. PubMed ID: 23108185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of griseofulvin plain tablets in stomach-emptying controlled rabbits and the correlation with bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    J Pharmacobiodyn; 1984 Sep; 7(9):630-40. PubMed ID: 6527208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rabbits for GI drug absorption studies: relationship between dissolution rate and bioavailability of griseofulvin tablets.
    Maeda T; Takenaka H; Yamahira Y; Noguchi T
    J Pharm Sci; 1979 Oct; 68(10):1286-9. PubMed ID: 512862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physicochemical properties and intestinal absorption of a ground mixture of chloramphenicol palmitate with microcrystalline cellulose (author's transl].
    Yamamoto K; Matsuda S; Nakano M; Arita T; Nakai Y
    Yakugaku Zasshi; 1977 Apr; 97(4):367-72. PubMed ID: 559740
    [No Abstract]   [Full Text] [Related]  

  • 13. Micronization: a method of improving the bioavailability of poorly soluble drugs.
    Chaumeil JC
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):211-5. PubMed ID: 9646283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal absorption of griseofulvin from a triolein digestion mixture in rats.
    Grisafe JA; Hayton WL
    J Pharm Sci; 1978 Jul; 67(7):895-9. PubMed ID: 660503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of griseofulvin from plain tablets in Göttingen minipigs and the correlation with bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Yasuda Y; Tanioka Y
    J Pharmacobiodyn; 1984 Jan; 7(1):7-14. PubMed ID: 6726615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of highly compressible Ceolus™ microcrystalline cellulose for improved dosage form properties containing a hydrophilic solid dispersion.
    Dinunzio JC; Schilling SU; Coney AW; Hughey JR; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Feb; 38(2):180-9. PubMed ID: 21774741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    J Pharmacobiodyn; 1982 Feb; 5(2):120-4. PubMed ID: 7097474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of increased griseofulvin bioavailability with p-hydroxy acetophenone.
    Wu SX; Huang WL; Jin WQ
    Chin Med J (Engl); 1981 Apr; 94(4):237-40. PubMed ID: 6790239
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
    Rojas J; Kumar V
    Pharmazie; 2012 Jul; 67(7):595-7. PubMed ID: 22888514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat contents of meals and bioavailability of griseofulvin in man.
    Ogunbona FA; Smith IF; Olawoye OS
    J Pharm Pharmacol; 1985 Apr; 37(4):283-4. PubMed ID: 2860234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.